After fifteen years studying the effects of electrical fields on cancer cell division, Novocure developed an innovative cancer treatment that treats without the side effects of radiation or chemotherapy. Their FDA-approved therapy delivered through Optune — TTFields (tumor treating fields) technology — has proved effective in treating Glioblastoma, one of the most deadly cancers. The technology is now being tested on a range of other cancers, and shows promising results.
AAJdesign was brought in to refine, elevate, and give life to Novocure’s brand, and develop a new communications platform, ‘Patient Forward,’ to help them connect with patients, investors, and the scientific and regulatory communities. As part of these efforts, AAJdesign designed a new, more refined logotype, wrote and created comprehensive application standards, and designed their first digital and print annual report, as well as other critical business communications.